Fortress: Eye on Deals
Airtime: Tues. Jul. 6 2010 |
Private equity firm Fortress Investment Group has made two deals in the commercial real estate arena. Daniel Mudd, CEO of the Fortress Investment Group, discusses the deals with CNBC.
Similar Posts
Study Identifies Heart Risks in Glaxo's Avandia
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.
Trader Talk With Art Cashin 3.26.10
Art Cashin, head of floor operations at UBS, has the buzz from the NYSE.
Bill Miller: A Veteran of Value
Insight on value investing, with Bill Miller, Legg Mason Capital Management.
Story of the Week: IPOs
Six IPOs are scheduled for this week, with CNBC’s Bob Pisani.
Gillard Likely to Stick With Mining Tax
Even if Julia Gillard takes over the PM seat in Australia, the proposed mining tax will still remain, says Colin Chapman, Asia Pacific VP at Strategic Forecasting. He makes his case to Brian Coulton of Fitch Ratings, CNBC’s Martin Soong, Karen Tso & Sri Jegarajah.
Free Credit Reports, No Longer Free?
Airtime: Thurs. Apr. 8 2010 | 4:44 PM ET Experian charges consumers $1 for “free” credit reports, with CNBC’s Hampton Pearson.